genedrive (LON:GDR) Stock Price Up 11.6% – What’s Next?

genedrive plc (LON:GDR) was up 11.6% on Friday . The stock traded as high as GBX 1.20 and last traded at GBX 1.20. Approximately 12,001,355 shares were traded during mid-day trading, an increase of 62% from the average daily volume of 7,390,355 shares. The stock had previously closed at GBX 1.08.

genedrive Stock Up 11.6%

The firm has a market cap of £12.36 million, a P/E ratio of -1.33 and a beta of -0.04. The company has a quick ratio of 5.52, a current ratio of 4.60 and a debt-to-equity ratio of 0.35. The firm has a fifty day moving average of GBX 0.97 and a 200-day moving average of GBX 0.80.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.